Only a few months after stepping…
Only a few months after stepping into the role of [...]
Only a few months after stepping into the role of [...]
The pioneering Danish drugmaker was once the most valuable company [...]
With more than $1 billion in debt due in 2027, [...]
Werewolf Therapeutics is transforming its brand awareness and clinical trial [...]
The FDA approved Jazz’s Modeyso (dordaviprone), which was picked up [...]
President Donald Trump has doubled down on his plan to [...]
A quiet revolution in care is helping patients with cardiac [...]
As investors and industry watchers juggle the twin possibilities of [...]
The Swiss government said it had “no indication” the country [...]
While the JAK inhibitor market for alopecia areata has grown [...]